4'-hydroxy-3'-methoxyisoflavone.
A lab-built isoflavone carrying a methoxy group on the B ring. That change makes it more fat-loving and slower to conjugate than the soy isoflavones it resembles.
- Category
- Compound
What 4'-hydroxy-3'-methoxyisoflavone is, and what it does.
- Does it work
- Suits someone curious about isoflavone chemistry beyond soy. Human outcome data is absent, so what you have is a well-characterised molecule with an open question after it.
- How much to take
- No dose figure is on record and no human dosing study has been published. A meal containing fat is what helps an isoflavone aglycone dissolve and be absorbed.
- Time to feel it
- Nobody has measured a timeline in people. Isoflavones as a class reach peak blood levels within hours and are mostly circulating as conjugates by then.
- The first dose
- Nothing in the literature describes a day-one experience. The measurable event is absorption and first-pass conjugation across the first few hours.
- With regular use
- Weeks of daily use have not been studied for this molecule. Related isoflavones build a steady pool of circulating conjugates rather than a sensation.
- How well tolerated
- No human safety dataset exists for this compound. Isoflavones bind oestrogen receptors weakly, so anyone tracking their own hormonal balance should speak to a doctor first.
- How it feels
- Nobody has described a subjective effect. Any read on it would come from a hormone panel rather than from how you feel on the day.
- The overlooked benefit
- The methoxy group is the whole point. It slows the phase two conjugation that clears plain isoflavones quickly, so more of the free molecule survives the first pass.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Oestrogen receptor binding of isoflavone aglyconesIn vitro study
- Effect of B ring methoxylation on flavonoid lipophilicity and conjugationNarrative review
- Formulation vehicles improving isoflavone aglycone dissolutionIn vitro study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
This isoflavone is almost always sold inside a protein or post-training blend rather than on its own. The protein carries a real, well-characterised anabolic contribution from its leucine and total amino acid load. The isoflavone contribution in that same product has not been separated out in controlled human work. Read the pairing as commercial formulation rather than a demonstrated interaction.
Methoxylated isoflavone aglycones have low aqueous solubility, which limits how much dissolves in the gut before it can be absorbed. Formulating with a phospholipid such as lecithin creates a dispersed phase that improves dissolution. The same approach is used across the flavonoid and isoflavone class. Whether it changes systemic exposure of this specific molecule has not been published.
A poorly water-soluble aglycone taken with a fat source partitions into mixed micelles rather than sitting undissolved in the gut lumen. That is the general absorption route for lipophilic polyphenols. Medium chain triglycerides give a fast-emptying lipid vehicle for this purpose. No pharmacokinetic study has tested this pairing for this compound.
Isoflavones and flavonols are both heavily conjugated during first pass, with glucuronidation and sulfation dominating. Taking two substrates for the same enzymes together raises the load on that pathway and can change how much of either reaches circulation unconjugated. The direction of the net effect depends on the doses involved. This is enzyme kinetics rather than a measured supplement interaction.
The gut microbial community converts isoflavones into downstream metabolites, and the capacity to do so is not universal across individuals. That is well established for the soy isoflavone family. A live culture that changes community composition could plausibly change the metabolite mix. Whether this happens for this specific methoxylated compound has not been tested.
Piperine reduces the activity of gut wall UGT enzymes, which is why it raises systemic exposure to several heavily conjugated polyphenols. Isoflavones are cleared largely by that same conjugation step. The pairing is therefore mechanistically reasonable. It has been measured for other polyphenols, not for this molecule, so the size of any change here is unknown.
Creatine has a deep and consistent evidence base for strength and lean mass outcomes. This isoflavone does not, and it appears alongside creatine because of category convention rather than a studied interaction. Nothing suggests a chemical conflict between them. The honest framing is that one partner is carrying the evidence.
Fat-soluble compounds taken in the same lipid-containing meal share the mixed micelle carrier and the same dependence on bile flow. Co-dosing with a meal that contains fat improves the dissolution position of both. There is no evidence of competition at typical supplement doses. This is a delivery observation rather than a functional synergy.
Nothing specific on file for 4'-hydroxy-3'-methoxyisoflavone. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What 4'-hydroxy-3'-methoxyisoflavone actually does.
This is a modified isoflavone related to the soy isoflavone family, with an extra methoxy group attached.
Isoflavones like this one don't dissolve well in water, and how well they're absorbed depends on how well they dissolve in the gut, which is why fat or phospholipid-based formulations are used.
After absorption, most isoflavones get heavily modified by the intestine and liver, so most of what circulates in your blood is in a modified form rather than the original compound.
Isoflavones as a group can weakly bind to estrogen receptors, with a preference for one particular subtype, though how strongly varies a lot depending on the exact molecule.
Where 4'-hydroxy-3'-methoxyisoflavone comes from.
It is made in a lab, not pulled out of a plant. Chemists build the ring structure from simpler pieces, then purify it and check the result with chromatography. That means the certificate of analysis is what tells you what you have, since there is no plant source to point at.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Commercial material is built from methoxy- and hydroxy-substituted phenolic and benzofuran-type starting materials rather than isolated from a plant.
The benzopyranone ring system is assembled by standard synthetic routes used across the isoflavone class, setting the hydroxy and methoxy positions.
The crude product is recrystallised from solvent to remove positional isomers and synthesis residues.
Purity is declared by chromatographic assay against a reference standard, typically at or above 98 percent.
Milled to a target particle size, then encapsulated directly or pre-dispersed in a lipid or cyclodextrin carrier.
The forms it comes in.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.